Bullous pemphigoid after anti-programmed death-1 therapy: A retrospective case-control study evaluating impact on tumor response and survival outcomes.

J Am Acad Dermatol

Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Cutaneous Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Electronic address:

Published: December 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.12.068DOI Listing

Publication Analysis

Top Keywords

bullous pemphigoid
4
pemphigoid anti-programmed
4
anti-programmed death-1
4
death-1 therapy
4
therapy retrospective
4
retrospective case-control
4
case-control study
4
study evaluating
4
evaluating impact
4
impact tumor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!